http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 02 May 2024 07:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Press+Releases/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Visit StreetInsider.com at http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html for the full story. http://www.streetinsider.com/Business+Wire/CALQUENCE+combination+regimen+demonstrated+statistically+significant+and+clinically+meaningful+improvement+in+progression-free+survival+in+1st-line+mantle+cell+lymphoma+in+ECHO+Phase+III+trial/23159578.html Thu, 02 May 2024 07:00:00 -0400 A.33615634 A.60012009 AZN AZN AZN GRCL O.00436461 O.07116439 O.19987510 O.49500139 http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html for the full story. http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Tue, 30 Apr 2024 00:30:00 -0400 01801 1801 6IB A.01956573 A.03607790 A.04794336 A.16478122 A.33615634 A.39530650 A.50200199 GRCL IVBIY O.07116439 O.08044614 O.10557543 O.20147506 O.22555989 O.39140405 O.49500139 O.49891921 O.50744962 http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html for the full story. http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Tue, 30 Apr 2024 00:30:00 -0400 01801 1801 6IB A.01956573 A.03607790 A.04794336 A.16478122 A.33615634 A.39530650 A.50200199 GRCL IVBIY O.07116439 O.08044614 O.10557543 O.20147506 O.22555989 O.39140405 O.49500139 O.49891921 O.50744962 http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html for the full story. http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Tue, 30 Apr 2024 00:30:00 -0400 01801 1801 6IB A.01956573 A.03607790 A.04794336 A.16478122 A.33615634 A.39530650 A.50200199 GRCL IVBIY O.07116439 O.08044614 O.10557543 O.20147506 O.22555989 O.39140405 O.49500139 O.49891921 O.50744962 http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html for the full story. http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Tue, 30 Apr 2024 00:30:00 -0400 01801 1801 6IB A.01956573 A.03607790 A.04794336 A.16478122 A.33615634 A.39530650 A.50200199 GRCL IVBIY O.07116439 O.08044614 O.10557543 O.20147506 O.22555989 O.39140405 O.49500139 O.49891921 O.50744962 http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html for the full story. http://www.streetinsider.com/Press+Releases/Innovent+Announces+the+Appointment+of+Dr.+Samuel+Zhang+as+Global+Chief+Business+Officer+%28CBO%29/23140185.html Tue, 30 Apr 2024 00:30:00 -0400 01801 1801 6IB A.01956573 A.03607790 A.04794336 A.16478122 A.33615634 A.39530650 A.50200199 GRCL IVBIY O.07116439 O.08044614 O.10557543 O.20147506 O.22555989 O.39140405 O.49500139 O.49891921 O.50744962